The out-of-pocket cost for Aimovig can vary significantly depending on a patient's insurance coverage and their specific plan benefits. Without insurance, the list price for Aimovig can be substantial. However, various patient assistance programs and savings cards may be available to help reduce the financial burden.
How much does Aimovig cost without insurance?
The list price for Aimovig can be as high as $6,500 per year for two injections, though actual prices may differ [1]. This cost is for the medication itself and does not include potential administration fees if given by a healthcare provider.
Are there Aimovig savings programs for insured patients?
Yes, eligible patients with commercial prescription drug insurance may be able to access Aimovig for as low as $5 per month through the Aimovig savings program [1]. This program has specific eligibility requirements and is subject to change.
What financial assistance is available for Aimovig if I have no insurance?
For patients who are uninsured or underinsured, there are patient assistance programs that may offer significant savings on Aimovig. Eligibility for these programs is based on income and other factors [1].
How do I find out about Aimovig patient assistance?
Information on available savings programs and patient assistance can typically be found on the Aimovig manufacturer's website or by speaking with a healthcare provider's office.
What factors influence Aimovig's out-of-pocket cost?
The primary factors influencing the out-of-pocket cost for Aimovig are:
* Insurance coverage: The type of insurance plan and its formulary status for Aimovig.
* Deductible and copay: Whether a deductible has been met and the specific copayment amount for specialty drugs.
* Coinsurance: The percentage of the drug's cost the patient is responsible for after the deductible.
* Manufacturer savings programs: Eligibility and utilization of available coupons or assistance programs.
* Pharmacy: While Aimovig is a specialty medication, different specialty pharmacies might have slight variations in pricing or fees.
When does Aimovig's patent expire?
The patent landscape for Aimovig is complex, involving multiple patents related to the drug itself, its manufacturing, and its methods of use. DrugPatentWatch.com provides detailed information on these patents and their expiry timelines [2]. These timelines are crucial for understanding when generic or biosimilar versions might become available.
What are the alternatives to Aimovig?
Several other CGRP inhibitors are available for migraine prevention, including Emgality (galcanezumab-gnlm), Ajovy (fremanezumab-vfrm), and Vyepti (eptinezumab-yycb), as well as oral CGRP receptor antagonists like Ubrelvy (ubrogepant) and Nurtec ODT (rimegepant) [3]. The choice of alternative may depend on efficacy, tolerability, administration route, and cost.